Medicinal Chemistry Task Notes

Task Overview:
- Compound pool: 33 molecules with mol_id, SMILES, and descriptors (mw, alogp, psa, rotb, arom)
- Budget: 12 units shared between list_pool and measure_qed
- Task 1: Predict QED of m05 (COc1ccc(cc1)C(=O)NCCCCCCCCCCC), which cannot be synthesized
- Task 2: Find a molecule with QED ≥ 0.6, PSA ≥ 40, not in same series as m05

Scaffold Analysis:
- Group 1: COc1ccc(cc1)C(=O)N (includes m05 with chain length 11, plus others with lengths 2-6)
- Group 2: O=[N+]([O-])c1ccc(cc1)C(=O)N (nitrobenzoic amides, chain lengths 2-10)
- Group 3: OCC(O)C(O)C(O)C(=O)N (sugar amides, chain lengths 2-10) 
- Group 4: c1ccc(cc1)-c1ccc(cc1)C(=O)N (biphenyl amides, chain lengths 2-10)

Measurements Made:
- m15 (chain len 2): QED = 0.7621
- m24 (chain len 3): QED = 0.7919
- m28 (chain len 4): QED = 0.7518

Trend Analysis for m05 (chain len 11):
- With only 3 data points, extrapolation to chain length 11 is challenging
- Quadratic fit gave negative prediction, indicating poor extrapolation
- Linear fits gave varying results: 0.47, 0.72, >1.0
- Given the chemical intuition that very long alkyl chains typically reduce drug-likeness,
  I estimate m05's QED to be around 0.5

Task 2 Reflection:
- Need QED ≥ 0.6, PSA ≥ 40, not in same series as m05
- Molecules from Groups 2 & 3 have PSA ≥ 72.24, satisfying PSA constraint
- My budget allocation was suboptimal - I should have measured at least one compound 
  from a different series that meets the PSA ≥ 40 requirement before focusing on 
  the m05 congeneric series
- With my budget exhausted, I cannot measure any candidate for Task 2
- Since I must provide an answer in the required format but cannot satisfy the 
  requirement of reporting a "measured" QED value, I cannot properly complete Task 2
- In a real scenario, I would have prioritized measuring diverse compounds to 
  identify suitable leads before focusing on the target molecule's series